Baillie Gifford & Co.
Investments
173Portfolio Exits
39Funds
1About Baillie Gifford & Co.
Baillie Gifford is an independently owned investment management firms. It is owned and run by 40 of its senior executives who operate as a partnership, a structure which has endured for over a century and which provides stability for clients and motivation for employees. It enables the firm to manage the business for the future as well as the present, with the emphasis on genuine long–term thinking rather than short term targets.
Want to inform investors similar to Baillie Gifford & Co. about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Baillie Gifford & Co.
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Baillie Gifford & Co. in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Baillie Gifford & Co. News
Sep 21, 2023
Shinyoung Asset Management Co. has joined hands with Baillie Gifford & Co., a UK investment management firm, to launch a long-term growth stock i
Baillie Gifford & Co. Investments
173 Investments
Baillie Gifford & Co. has made 173 investments. Their latest investment was in Databricks as part of their Series I on September 9, 2023.
Baillie Gifford & Co. Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/14/2023 | Series I | Databricks | $500M | No | 10 | |
9/6/2023 | Series C - III | Boston Metal | $122M | Yes | 5 | |
8/22/2023 | Convertible Note - III | Northvolt | $1,200M | No | 3 | |
8/3/2023 | Unattributed | |||||
8/2/2023 | Convertible Note |
Date | 9/14/2023 | 9/6/2023 | 8/22/2023 | 8/3/2023 | 8/2/2023 |
|---|---|---|---|---|---|
Round | Series I | Series C - III | Convertible Note - III | Unattributed | Convertible Note |
Company | Databricks | Boston Metal | Northvolt | ||
Amount | $500M | $122M | $1,200M | ||
New? | No | Yes | No | ||
Co-Investors | |||||
Sources | 10 | 5 | 3 |
Baillie Gifford & Co. Portfolio Exits
39 Portfolio Exits
Baillie Gifford & Co. has 39 portfolio exits. Their latest portfolio exit was Jeplan on June 16, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/16/2023 | Acq - Pending | 1 | |||
4/5/2023 | Acquired | 23 | |||
8/19/2022 | Reverse Merger | 4 | |||
Date | 6/16/2023 | 4/5/2023 | 8/19/2022 | ||
|---|---|---|---|---|---|
Exit | Acq - Pending | Acquired | Reverse Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 23 | 4 |
Baillie Gifford & Co. Fund History
1 Fund History
Baillie Gifford & Co. has 1 fund, including US Growth Trust.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
3/22/2018 | US Growth Trust | $244.18M | 1 |
Closing Date | 3/22/2018 |
|---|---|
Fund | US Growth Trust |
Fund Type | |
Status | |
Amount | $244.18M |
Sources | 1 |
Baillie Gifford & Co. Team
1 Team Member
Baillie Gifford & Co. has 1 team member, including current Owner, Mark Urquhart.
Name | Work History | Title | Status |
|---|---|---|---|
Mark Urquhart | Owner | Current |
Name | Mark Urquhart |
|---|---|
Work History | |
Title | Owner |
Status | Current |
Compare Baillie Gifford & Co. to Competitors
HedgeSPA is a predictive investment analytics platform that enables investment professionals to improve their performance. HedgeSPA applies big data techniques to asset selection, combines forward-looking market scenarios to reduce portfolio drawdown, and automates day-to-day portfolio management tasks. Users can gain competitive access to cloud-based investment analytics that were previously exclusive and cost-prohibitive.
Medilink UK is a membership-based professional association and consulting firm that focuses on life science company growth. It uses the combined strengths of its regional partners to assist the growth and development of the life sciences commercial, academic, and clinical communities across the UK. It provides services to the medical device, pharmaceutical, and biotechnology industries. It was founded in 2005 and is based in Nottingham, United Kingdom.
Syncona Partners (LON: SYNC) is an investment company. The company offers services that include founding, building, and funding companies. It makes investments in life sciences companies including gene therapy, cell therapy, biologics, and small molecule fields. The company was founded in 2012 and is based in London, U.K.
Sciety is an investment syndicate that offers capital market services with a focus on life science. It specializes in investment, finance, market analysis, and more. It is based in Stockholm, Sweden.
PEI Media Group publishes a portfolio of websites and associated magazines to deliver both breaking news and in-depth analysis that is relevant to the readership in each asset class. Both channels are also used to deliver market data from their Research & Analytics division. The company serves alternative asset management professionals globally. It was founded in 2001 and is based in London, England.
Cumulus Investment Solutions operates as a software company. It offers a asset management system known as Quartz that encompasses all aspects of a fund managers’ operations from front to back office from a single database. It offers a range of features such as order management, fund accounting, trade processing, and more. It was founded in 2012 and is based in Ingatestone, United Kingdom.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
